These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 8034724

  • 1. Conversion of plasminogen activator inhibitor-1 from inhibitor to substrate by point mutations in the reactive-site loop.
    Audenaert AM, Knockaert I, Collen D, Declerck PJ.
    J Biol Chem; 1994 Jul 29; 269(30):19559-64. PubMed ID: 8034724
    [Abstract] [Full Text] [Related]

  • 2. Proteinase specificity and functional diversity in point mutants of plasminogen activator inhibitor 1.
    Gils A, Declerck PJ.
    J Biol Chem; 1997 May 09; 272(19):12662-6. PubMed ID: 9139722
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Selective screening of a large phage display library of plasminogen activator inhibitor 1 mutants to localize interaction sites with either thrombin or the variable region 1 of tissue-type plasminogen activator.
    van Meijer M, Roelofs Y, Neels J, Horrevoets AJ, van Zonneveld AJ, Pannekoek H.
    J Biol Chem; 1996 Mar 29; 271(13):7423-8. PubMed ID: 8631768
    [Abstract] [Full Text] [Related]

  • 6. Characterization of plasminogen activator inhibitor 1 mutants containing the P13 to P10 region of ovalbumin or antithrombin III: evidence that the P13 residue contributes significantly to the active to substrate transition.
    Gils A, Vleugels N, Tobback K, Knockaert I, Declerck PJ.
    Biochim Biophys Acta; 1998 Sep 08; 1387(1-2):291-7. PubMed ID: 9748634
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Identification of positively charged residues contributing to the stability of plasminogen activator inhibitor 1.
    Gils A, Lu J, Aertgeerts K, Knockaert I, Declerck PJ.
    FEBS Lett; 1997 Sep 29; 415(2):192-5. PubMed ID: 9350994
    [Abstract] [Full Text] [Related]

  • 9. Serpin reactive center loop mobility is required for inhibitor function but not for enzyme recognition.
    Lawrence DA, Olson ST, Palaniappan S, Ginsburg D.
    J Biol Chem; 1994 Nov 04; 269(44):27657-62. PubMed ID: 7961684
    [Abstract] [Full Text] [Related]

  • 10. A novel form of the plasminogen activator inhibitor created by cysteine mutations extends its half-life: relevance to cancer and angiogenesis.
    Chorostowska-Wynimko J, Swiercz R, Skrzypczak-Jankun E, Wojtowicz A, Selman SH, Jankun J.
    Mol Cancer Ther; 2003 Jan 04; 2(1):19-28. PubMed ID: 12533669
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Conformational changes of the reactive-centre loop and beta-strand 5A accompany temperature-dependent inhibitor-substrate transition of plasminogen-activator inhibitor 1.
    Kjøller L, Martensen PM, Sottrup-Jensen L, Justesen J, Rodenburg KW, Andreasen PA.
    Eur J Biochem; 1996 Oct 01; 241(1):38-46. PubMed ID: 8898886
    [Abstract] [Full Text] [Related]

  • 13. Engineering plasminogen activator inhibitor 1 mutants with increased functional stability.
    Lawrence DA, Olson ST, Palaniappan S, Ginsburg D.
    Biochemistry; 1994 Mar 29; 33(12):3643-8. PubMed ID: 8142362
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Characterization of the binding of urokinase-type plasminogen activator (u-PA) to plasminogen, to plasminogen-activator inhibitor-1 and to the u-PA receptor.
    Lijnen HR, De Cock F, Collen D.
    Eur J Biochem; 1994 Sep 01; 224(2):567-74. PubMed ID: 7925373
    [Abstract] [Full Text] [Related]

  • 17. Biochemical and biophysical studies of reactive center cleaved plasminogen activator inhibitor type 1. The distance between P3 and P1' determined by donor-donor fluorescence energy transfer.
    Aleshkov SB, Fa M, Karolin J, Strandberg L, Johansson LB, Wilczynska M, Ny T.
    J Biol Chem; 1996 Aug 30; 271(35):21231-8. PubMed ID: 8702896
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop.
    Dekker RJ, Eichinger A, Stoop AA, Bode W, Pannekoek H, Horrevoets AJ.
    J Mol Biol; 1999 Oct 29; 293(3):613-27. PubMed ID: 10543954
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.